Using a growth factor produced naturally by the human body – and used in spinal-fusion surgeries – scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have coaxed “leftover” cells from the...
Ellen H Ullman, MSW's insight:
Rodent studies. Next step "animal studies". Let's hope HUMANS will someday benefit from this research.
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes (T1D), led by UC San Francisco scientists and physicians, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected to protect the body's ability to produce insulin.
A new technique to produce cells with insulin-secretion capabilities has been developed, according to research presented today at the 54th Annual European Society for Paediatric Endocrinology Meeting. The technique could be further developed to be used in the transplantation for patients with type 1 diabetes.
Emergency physicians should consider switching from D50W to the safer, less error-prone, equally effective D10W when treating hypoglycemia. “An amp of D50” – 25 grams of glucose in a 50 mlprefilled syringe (50% glucose) – is, and has been since at least the middle of the last century, a standard parenteral treatment by U.S. emergency physiciansRead More
Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes. The treatment combines INGAP Peptide (ExsulinTM), which stimulates growth of the insulin secreting islets, and ustekinumab (SteleraTM), a drug approved for the treatment of psoriasis.
Call it the scientist’s version of happy hour: A new, four-drug cocktail has shown a novel ability to reverse established Type 1 diabetes in some mice, University of Florida Health researchers have found.
Randomized cross-over design (11 days bionic pancreas, 11 days usual care)Subjects work or study on one of four campusesMGH, UNC Chapel Hill, Stanford, UMass Medical Center10 subjects per site (40 total)Normal daily routine, no restrictions on diet or exerciseRemote monitoring of alarms in BP, call subject if not response to alarms
Ellen H Ullman, MSW's insight:
Thank you Joshua Levy for sharing this via Twitter
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.